Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
- Status
- TERMINATED
- Phase
- PHASE3
Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Optimized Intensity Modulated Irradiation for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- NA
Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2